| ■ 영문 제목 : Global Oral Transmucosal Drugs Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02122 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 115 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 경구 경점막 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (정제, 필름, 액체 스프레이, 젤, 기타)와 용도별 시장규모 (심혈관 장애, 급성 동통 관리, 당뇨병, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 경구 경점막 약물 시장 점유율 - 지역별 경구 경점막 약물 시장규모 - 주요지역의 종류별 시장규모 (정제, 필름, 액체 스프레이, 젤, 기타) - 주요지역의 용도별 시장규모 (심혈관 장애, 급성 동통 관리, 당뇨병, 기타) - 미주의 경구 경점막 약물 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 경구 경점막 약물 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 경구 경점막 약물 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 경구 경점막 약물 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 경구 경점막 약물 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) LTS Lohmann Therapie-Systeme AG, Soligenix, ZIM Laboratories Limited, Access Pharmaceutical Inc., C.L Pharm, Cure Pharmaceutical, Aquestive Therapeutics, Inc., NAL Pharma, IntelGenx Corp., Eisai Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Viatris, Bristol-Myers Squibb Company - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Oral Transmucosal Drugs will have significant change from previous year. By the most conservative estimates of global Oral Transmucosal Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in 2020. Over the next five years the Oral Transmucosal Drugs market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Transmucosal Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Tablets
Films
Liquid Spray
Gels
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Cardiovascular Disorders
Acute Pain Managements
Diabetes
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
LTS Lohmann Therapie-Systeme AG
Soligenix
ZIM Laboratories Limited
Access Pharmaceutical Inc.
C.L Pharm
Cure Pharmaceutical
Aquestive Therapeutics, Inc.
NAL Pharma
IntelGenx Corp.
Eisai Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Viatris
Bristol-Myers Squibb Company
1 Scope of the Report 2 Executive Summary 3 Global Oral Transmucosal Drugs by Company 4 Oral Transmucosal Drugs by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Oral Transmucosal Drugs Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Oral Transmucosal Drugs Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Tablets Table 3. Major Players of Films Table 4. Major Players of Liquid Spray Table 5. Major Players of Gels Table 6. Major Players of Others Table 7. Global Oral Transmucosal Drugs Sales by Type (2016-2021) & (K Units) Table 8. Global Oral Transmucosal Drugs Sales Market Share by Type (2016-2021) Table 9. Global Oral Transmucosal Drugs Revenue by Type (2016-2021) & ($ million) Table 10. Global Oral Transmucosal Drugs Revenue Market Share by Type (2016-2021) Table 11. Global Oral Transmucosal Drugs Sale Price by Type (2016-2021) Table 12. Global Oral Transmucosal Drugs Sales by Application (2016-2021) & (K Units) Table 13. Global Oral Transmucosal Drugs Sales Market Share by Application (2016-2021) Table 14. Global Oral Transmucosal Drugs Value by Application (2016-2021) Table 15. Global Oral Transmucosal Drugs Revenue Market Share by Application (2016-2021) Table 16. Global Oral Transmucosal Drugs Sale Price by Application (2016-2021) Table 17. Global Oral Transmucosal Drugs Sales by Company (2019-2021) & (K Units) Table 18. Global Oral Transmucosal Drugs Sales Market Share by Company (2019-2021) Table 19. Global Oral Transmucosal Drugs Revenue by Company (2019-2021) ($ Millions) Table 20. Global Oral Transmucosal Drugs Revenue Market Share by Company (2019-2021) Table 21. Global Oral Transmucosal Drugs Sale Price by Company (2019-2021) Table 22. Key Manufacturers Oral Transmucosal Drugs Producing Area Distribution and Sales Area Table 23. Players Oral Transmucosal Drugs Products Offered Table 24. Oral Transmucosal Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 25. New Products and Potential Entrants Table 26. Mergers & Acquisitions, Expansion Table 27. Global Oral Transmucosal Drugs Sales by Region (2016-2021) (K Units) Table 28. Global Oral Transmucosal Drugs Sales Market Share by Region (2016-2021) Table 29. Global Oral Transmucosal Drugs Revenue by Region (2016-2021) & ($ Millions) Table 30. Global Oral Transmucosal Drugs Revenue Market Share by Region (2016-2021) Table 31. Americas Oral Transmucosal Drugs Sales by Country (2016-2021) & (K Units) Table 32. Americas Oral Transmucosal Drugs Sales Market Share by Country (2016-2021) Table 33. Americas Oral Transmucosal Drugs Revenue by Country (2016-2021) & ($ Millions) Table 34. Americas Oral Transmucosal Drugs Revenue Market Share by Country (2016-2021) Table 35. Americas Oral Transmucosal Drugs Sales by Type (2016-2021) & (K Units) Table 36. Americas Oral Transmucosal Drugs Sales Market Share by Type (2016-2021) Table 37. Americas Oral Transmucosal Drugs Sales by Application (2016-2021) & (K Units) Table 38. Americas Oral Transmucosal Drugs Sales Market Share by Application (2016-2021) Table 39. APAC Oral Transmucosal Drugs Sales by Region (2016-2021) & (K Units) Table 40. APAC Oral Transmucosal Drugs Sales Market Share by Region (2016-2021) Table 41. APAC Oral Transmucosal Drugs Revenue by Region (2016-2021) & ($ Millions) Table 42. APAC Oral Transmucosal Drugs Revenue Market Share by Region (2016-2021) Table 43. APAC Oral Transmucosal Drugs Sales by Type (2016-2021) & (K Units) Table 44. APAC Oral Transmucosal Drugs Sales Market Share by Type (2016-2021) Table 45. APAC Oral Transmucosal Drugs Sales by Application (2016-2021) & (K Units) Table 46. APAC Oral Transmucosal Drugs Sales Market Share by Application (2016-2021) Table 47. Europe Oral Transmucosal Drugs Sales by Country (2016-2021) & (K Units) Table 48. Europe Oral Transmucosal Drugs Sales Market Share by Country (2016-2021) Table 49. Europe Oral Transmucosal Drugs Revenue by Country (2016-2021) & ($ Millions) Table 50. Europe Oral Transmucosal Drugs Revenue Market Share by Country (2016-2021) Table 51. Europe Oral Transmucosal Drugs Sales by Type (2016-2021) & (K Units) Table 52. Europe Oral Transmucosal Drugs Sales Market Share by Type (2016-2021) Table 53. Europe Oral Transmucosal Drugs Sales by Application (2016-2021) & (K Units) Table 54. Europe Oral Transmucosal Drugs Sales Market Share by Application (2016-2021) Table 55. Middle East & Africa Oral Transmucosal Drugs Sales by Country (2016-2021) & (K Units) Table 56. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Country (2016-2021) Table 57. Middle East & Africa Oral Transmucosal Drugs Revenue by Country (2016-2021) & ($ Millions) Table 58. Middle East & Africa Oral Transmucosal Drugs Revenue Market Share by Country (2016-2021) Table 59. Middle East & Africa Oral Transmucosal Drugs Sales by Type (2016-2021) & (K Units) Table 60. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Type (2016-2021) Table 61. Middle East & Africa Oral Transmucosal Drugs Sales by Application (2016-2021) & (K Units) Table 62. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Application (2016-2021) Table 63. Key and Potential Regions of Oral Transmucosal Drugs Table 64. Key Application and Potential Industries of Oral Transmucosal Drugs Table 65. Key Challenges of Oral Transmucosal Drugs Table 66. Key Trends of Oral Transmucosal Drugs Table 67. Oral Transmucosal Drugs Distributors List Table 68. Oral Transmucosal Drugs Customer List Table 69. Global Oral Transmucosal Drugs Sales Forecast by Region (2021-2026) & (K Units) Table 70. Global Oral Transmucosal Drugs Consumption Market Forecast by Region Table 71. Global Oral Transmucosal Drugs Revenue Forecast by Region (2021-2026) & ($ millions) Table 72. Global Oral Transmucosal Drugs Revenue Market Share Forecast by Region (2021-2026) Table 73. Americas Oral Transmucosal Drugs Sales Forecast by Country (2021-2026) & (K Units) Table 74. Americas Oral Transmucosal Drugs Revenue Forecast by Country (2021-2026) & ($ millions) Table 75. APAC Oral Transmucosal Drugs Sales Forecast by Region (2021-2026) & (K Units) Table 76. APAC Oral Transmucosal Drugs Revenue Forecast by Region (2021-2026) & ($ millions) Table 77. Europe Oral Transmucosal Drugs Sales Forecast by Country (2021-2026) & (K Units) Table 78. Europe Oral Transmucosal Drugs Revenue Forecast by Country (2021-2026) & ($ millions) Table 79. Middle East & Africa Oral Transmucosal Drugs Sales Forecast by Country (2021-2026) & (K Units) Table 80. Middle East & Africa Oral Transmucosal Drugs Revenue Forecast by Country (2021-2026) & ($ millions) Table 81. Global Oral Transmucosal Drugs Sales Forecast by Type (2021-2026) & (K Units) Table 82. Global Oral Transmucosal Drugs Sales Market Share Forecast by Type (2021-2026) Table 83. Global Oral Transmucosal Drugs Revenue Forecast by Type (2021-2026) & ($ Millions) Table 84. Global Oral Transmucosal Drugs Revenue Market Share Forecast by Type (2021-2026) Table 85. Global Oral Transmucosal Drugs Sales Forecast by Application (2021-2026) & (K Units) Table 86. Global Oral Transmucosal Drugs Sales Market Share Forecast by Application (2021-2026) Table 87. Global Oral Transmucosal Drugs Revenue Forecast by Application (2021-2026) & ($ Millions) Table 88. Global Oral Transmucosal Drugs Revenue Market Share Forecast by Application (2021-2026) Table 89. LTS Lohmann Therapie-Systeme AG Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors Table 90. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Offered Table 91. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 92. LTS Lohmann Therapie-Systeme AG Main Business Table 93. LTS Lohmann Therapie-Systeme AG Latest Developments Table 94. Soligenix Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors Table 95. Soligenix Oral Transmucosal Drugs Product Offered Table 96. Soligenix Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 97. Soligenix Main Business Table 98. Soligenix Latest Developments Table 99. ZIM Laboratories Limited Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors Table 100. ZIM Laboratories Limited Oral Transmucosal Drugs Product Offered Table 101. ZIM Laboratories Limited Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 102. ZIM Laboratories Limited Main Business Table 103. ZIM Laboratories Limited Latest Developments Table 104. Access Pharmaceutical Inc. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors Table 105. Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Offered Table 106. Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 107. Access Pharmaceutical Inc. Main Business Table 108. Access Pharmaceutical Inc. Latest Developments Table 109. C.L Pharm Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors Table 110. C.L Pharm Oral Transmucosal Drugs Product Offered Table 111. C.L Pharm Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 112. C.L Pharm Main Business Table 113. C.L Pharm Latest Developments Table 114. Cure Pharmaceutical Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors Table 115. Cure Pharmaceutical Oral Transmucosal Drugs Product Offered Table 116. Cure Pharmaceutical Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 117. Cure Pharmaceutical Main Business Table 118. Cure Pharmaceutical Latest Developments Table 119. Aquestive Therapeutics, Inc. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors Table 120. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Offered Table 121. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 122. Aquestive Therapeutics, Inc. Main Business Table 123. Aquestive Therapeutics, Inc. Latest Developments Table 124. NAL Pharma Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors Table 125. NAL Pharma Oral Transmucosal Drugs Product Offered Table 126. NAL Pharma Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 127. NAL Pharma Main Business Table 128. NAL Pharma Latest Developments Table 129. IntelGenx Corp. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors Table 130. IntelGenx Corp. Oral Transmucosal Drugs Product Offered Table 131. IntelGenx Corp. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 132. IntelGenx Corp. Main Business Table 133. IntelGenx Corp. Latest Developments Table 134. Eisai Co., Ltd. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors Table 135. Eisai Co., Ltd. Oral Transmucosal Drugs Product Offered Table 136. Eisai Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 137. Eisai Co., Ltd. Main Business Table 138. Eisai Co., Ltd. Latest Developments Table 139. Otsuka Pharmaceutical Co., Ltd. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors Table 140. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Offered Table 141. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 142. Otsuka Pharmaceutical Co., Ltd. Main Business Table 143. Otsuka Pharmaceutical Co., Ltd. Latest Developments Table 144. Teva Pharmaceutical Industries Ltd. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors Table 145. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Offered Table 146. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 147. Teva Pharmaceutical Industries Ltd. Main Business Table 148. Teva Pharmaceutical Industries Ltd. Latest Developments Table 149. GlaxoSmithKline plc Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors Table 150. GlaxoSmithKline plc Oral Transmucosal Drugs Product Offered Table 151. GlaxoSmithKline plc Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 152. GlaxoSmithKline plc Main Business Table 153. GlaxoSmithKline plc Latest Developments Table 154. Viatris Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors Table 155. Viatris Oral Transmucosal Drugs Product Offered Table 156. Viatris Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 157. Viatris Main Business Table 158. Viatris Latest Developments Table 159. Bristol-Myers Squibb Company Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors Table 160. Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Offered Table 161. Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 162. Bristol-Myers Squibb Company Main Business Table 163. Bristol-Myers Squibb Company Latest Developments List of Figures Figure 1. Picture of Oral Transmucosal Drugs Figure 2. Oral Transmucosal Drugs Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Oral Transmucosal Drugs Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Oral Transmucosal Drugs Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Oral Transmucosal Drugs Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Tablets Figure 10. Product Picture of Films Figure 11. Product Picture of Liquid Spray Figure 12. Product Picture of Gels Figure 13. Product Picture of Others Figure 14. Global Oral Transmucosal Drugs Sales Market Share by Type in 2020 Figure 15. Global Oral Transmucosal Drugs Revenue Market Share by Type (2016-2021) Figure 16. Oral Transmucosal Drugs Consumed in Cardiovascular Disorders Figure 17. Global Oral Transmucosal Drugs Market: Cardiovascular Disorders (2016-2021) & (K Units) Figure 18. Oral Transmucosal Drugs Consumed in Acute Pain Managements Figure 19. Global Oral Transmucosal Drugs Market: Acute Pain Managements (2016-2021) & (K Units) Figure 20. Oral Transmucosal Drugs Consumed in Diabetes Figure 21. Global Oral Transmucosal Drugs Market: Diabetes (2016-2021) & (K Units) Figure 22. Oral Transmucosal Drugs Consumed in Others Figure 23. Global Oral Transmucosal Drugs Market: Others (2016-2021) & (K Units) Figure 24. Global Oral Transmucosal Drugs Sales Market Share by Application (2016-2021) Figure 25. Global Oral Transmucosal Drugs Revenue Market Share by Application in 2020 Figure 26. Oral Transmucosal Drugs Revenue Market by Company in 2020 ($ Million) Figure 27. Global Oral Transmucosal Drugs Revenue Market Share by Company in 2020 Figure 28. Global Oral Transmucosal Drugs Sales Market Share by Regions (2016-2021) Figure 29. Global Oral Transmucosal Drugs Revenue Market Share by Region in 2020 Figure 30. Americas Oral Transmucosal Drugs Sales 2016-2021 (K Units) Figure 31. Americas Oral Transmucosal Drugs Revenue 2016-2021 ($ Millions) Figure 32. APAC Oral Transmucosal Drugs Sales 2016-2021 (K Units) Figure 33. APAC Oral Transmucosal Drugs Revenue 2016-2021 ($ Millions) Figure 34. Europe Oral Transmucosal Drugs Sales 2016-2021 (K Units) Figure 35. Europe Oral Transmucosal Drugs Revenue 2016-2021 ($ Millions) Figure 36. Middle East & Africa Oral Transmucosal Drugs Sales 2016-2021 (K Units) Figure 37. Middle East & Africa Oral Transmucosal Drugs Revenue 2016-2021 ($ Millions) Figure 38. Americas Oral Transmucosal Drugs Sales Market Share by Country in 2020 Figure 39. Americas Oral Transmucosal Drugs Revenue Market Share by Country in 2020 Figure 40. Americas Oral Transmucosal Drugs Sales Market Share by Type in 2020 Figure 41. Americas Oral Transmucosal Drugs Sales Market Share by Application in 2020 Figure 42. United States Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 43. Canada Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 44. Mexico Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 45. Brazil Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 46. APAC Oral Transmucosal Drugs Sales Market Share by Region in 2020 Figure 47. APAC Oral Transmucosal Drugs Revenue Market Share by Regions in 2020 Figure 48. APAC Oral Transmucosal Drugs Sales Market Share by Type in 2020 Figure 49. APAC Oral Transmucosal Drugs Sales Market Share by Application in 2020 Figure 50. China Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 51. Japan Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 52. Korea Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 53. Southeast Asia Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 54. India Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 55. Australia Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 56. Europe Oral Transmucosal Drugs Sales Market Share by Country in 2020 Figure 57. Europe Oral Transmucosal Drugs Revenue Market Share by Country in 2020 Figure 58. Europe Oral Transmucosal Drugs Sales Market Share by Type in 2020 Figure 59. Europe Oral Transmucosal Drugs Sales Market Share by Application in 2020 Figure 60. Germany Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 61. France Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 62. UK Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 63. Italy Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 64. Russia Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 65. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Country in 2020 Figure 66. Middle East & Africa Oral Transmucosal Drugs Revenue Market Share by Country in 2020 Figure 67. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Type in 2020 Figure 68. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Application in 2020 Figure 69. Egypt Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 70. South Africa Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 71. Israel Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 72. Turkey Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 73. GCC Country Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions) Figure 74. Channels of Distribution Figure 75. Distributors Profiles |
| ※본 조사보고서 [세계의 경구 경점막 약물 시장예측 2021년-2026년] (코드 : LPI-2201K02122) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 경구 경점막 약물 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |